Cargando…
Where are the children in national hepatitis C policies? A global review of national strategic plans and guidelines
BACKGROUND & AIMS: It is estimated that 3.26 million children and adolescents worldwide have chronic HCV infection. To date, the global response has focused on the adult population, but direct-acting antiviral (DAA) regimens are now approved for children aged ≥3 years. This global review describ...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898178/ https://www.ncbi.nlm.nih.gov/pubmed/33665586 http://dx.doi.org/10.1016/j.jhepr.2021.100227 |